Pre-Filter Heparin Dosing for CRRT Circuit Clotting
For a patient experiencing circuit clotting on CRRT, initiate unfractionated heparin at 5-10 units/kg/hour as a continuous pre-filter infusion, titrating upward based on circuit performance while monitoring for bleeding complications.
Rationale and Approach
The KDIGO guidelines recommend anticoagulation for CRRT when patients lack bleeding risk or coagulopathy 1. While regional citrate anticoagulation is preferred over heparin for CRRT (Grade 2B recommendation) 1, your patient is already clotting, suggesting either inadequate anticoagulation or citrate is contraindicated/unavailable.
Specific Pre-Filter Heparin Dosing Strategy
When using unfractionated heparin for CRRT anticoagulation:
- Initial pre-filter bolus: 30 units/kg 2
- Maintenance infusion: Start at 5-10 units/kg/hour pre-filter 2, 3
- Target: Maintain circuit patency without achieving full systemic anticoagulation
- Titration: Increase in 2-5 units/kg/hour increments if clotting persists 3
The FDA label for extracorporeal dialysis suggests 25-30 units/kg bolus followed by 1,500-2,000 units/hour infusion 4, though this represents systemic rather than regional dosing.
Monitoring Parameters
- Circuit assessment: Evaluate filter pressures and visual clotting every 2-4 hours
- Systemic aPTT: Keep at 1.2-1.5 times control (lower than therapeutic anticoagulation) to minimize bleeding risk 3
- Platelet count: Daily monitoring for heparin-induced thrombocytopenia 4
- Bleeding signs: Continuous clinical surveillance
Evidence-Based Considerations
Research demonstrates that enoxaparin (0.15 mg/kg bolus, then 0.05 mg/kg/hour) provides superior filter life (30.6 hours) compared to unfractionated heparin (21.7 hours) with similar bleeding rates 2. However, low molecular weight heparins require anti-Xa monitoring and are problematic in renal failure.
Regional citrate anticoagulation achieves median filter survival of 48 hours versus 5.9 hours with heparin 5, with no increase in bleeding complications. If your patient continues clotting despite heparin optimization, strongly consider switching to citrate unless contraindicated by shock, severe liver failure, or citrate lock risk.
Critical Pitfalls to Avoid
- Underdosing: The most common error is using prophylactic rather than circuit-protective heparin doses
- Delayed escalation: If clotting occurs within 12-24 hours, increase heparin immediately rather than waiting for complete circuit failure
- Ignoring catheter dysfunction: Poor blood flow from malpositioned or thrombosed catheters causes clotting independent of anticoagulation—verify catheter function first
- Missing HIT: New thrombocytopenia (>50% drop) mandates immediate heparin cessation and switch to argatroban 1
Alternative Strategy if Heparin Fails
Nearly 41% of U.S. CRRT patients receive no anticoagulation 6, 7, with frequent saline flushes (every 30 minutes) providing comparable filter life (24.5 hours) to heparin (26 hours) when baseline aPTT is already elevated, while significantly reducing bleeding episodes 8. However, this approach increases nursing workload and circuit downtime.
The optimal solution for recurrent clotting remains transitioning to regional citrate anticoagulation 1, 5, 9, which the KDIGO guidelines explicitly recommend as superior to heparin for CRRT (Grade 2B) 1.